+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions



Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions



Cancer Research 45(3): 935-944




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 040806481

Download citation: RISBibTeXText

PMID: 3882226


Related references

Chemotherapy with Platinum Compounds: Current Status and Future Directions. Volume 3: Dosing, Head and Neck Cancer, Genitourinary Cancer, Pediatric Cancer, Tumor of Unknown Origin, Dose Intensity, Future Directions. Kona, Hawaii, February 24-28, 1993. Seminars in Oncology 21(5 Suppl 12): 1-118, 1994

Genotoxicity of tobacco smoke-derived aromatic amines and bladder cancer: current state of knowledge and future research directions. Faseb Journal 27(6): 2090-2100, 2013

Text mining of cancer-related information: review of current status and future directions. International Journal of Medical Informatics 83(9): 605-623, 2014

Carcinogenicity and metabolic activation of tobacco-specific nitrosamines: current status and future prospects. Iarc Scientific Publications 1984(57): 763-778, 1984

Smokeless tobacco: current status and future directions. British Journal of Addiction 86(5): 559-563, 1991

Adolescent and young adult tobacco prevention and cessation: current status and future directions. Tobacco Control 12(Suppl. 4): Iv46-Iv53, 2003

Nicotine-derived N-nitrosamines (TSNA) and their relevance in tobacco carcinogenesis. Critical Reviews in Toxicology 21(4): 305-311, 1991

Cancer immunotherapy: current status and future directions. Surgical Oncology Clinics of North America 22(4): 765-783, 2013

A critical analysis of approaches to targeted PTSD prevention: current status and theoretically derived future directions. Behavior Modification 31(1): 80, 2007

Docetaxel in breast cancer Current status and future directions. Cancer Investigation 17(Suppl. 1): 45-46, 1999

Lung cancer chemoprevention current status and future directions. Current Respiratory Care Reports 1(1): 9-20, 2012

Src inhibitors in lung cancer: current status and future directions. Clinical Lung Cancer 11(4): 238-242, 2010

Current status and future directions in the treatment of ovarian cancer. Proceedings of the American Association for Cancer Research Annual Meeting 37: 622-623, 1996

Targeted cancer therapies: current status and future directions. Current Medicinal Chemistry 18(11): 1573-1574, 2011

Current status and future directions in breast cancer therapy. Clinical Breast Cancer 4(Suppl. 2): S70-S75, 2003